The Continental landscape presents a unique evolution in the perception of psychedelics. Historically stigmatized, these substances are now receive attention for their medical applications. From the Netherlands, where research are underway, to the UK, where open conversations is growing, Europe plays a leading role in this re-evaluation of copyrigh